Eliz Lewis Amar

Title: Eliz Lewis Amar: Innovator in RNA Transfection Technologies

Introduction

Eliz Lewis Amar is a notable inventor based in Beer Sheva, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of RNA transfection. His innovative work has implications for gene therapy and the treatment of various diseases.

Latest Patents

Eliz Lewis Amar holds a patent for "Positively charged polysaccharides for RNA transfection." This patent describes a complex that includes RNA and a positively charged modified polysaccharide selected from starch, amylose, amylopectin, galactan, chitosan, or dextrin. The complex can be formed into a pharmaceutical composition and is applicable in methods for RNA transfection, gene therapy, and the treatment of diseases, disorders, or conditions. The positively charged modified polysaccharide can be effectively used in connection with RNA transfection into cells.

Career Highlights

Throughout his career, Eliz has worked with various organizations that focus on technological advancements. Notably, he has been associated with B.G. Negev Technologies and Applications Ltd. and Ramot at Tel Aviv University Ltd. His work in these institutions has allowed him to further develop his innovative ideas and contribute to the scientific community.

Collaborations

Eliz has collaborated with several professionals in his field, including Joseph Kost and Riki Goldbart. These collaborations have enriched his research and have led to advancements in RNA transfection technologies.

Conclusion

Eliz Lewis Amar is a pioneering inventor whose work in RNA transfection is paving the way for future advancements in gene therapy. His contributions are vital to the ongoing research and development in biotechnology.